Previous close | 2.1000 |
Open | 2.1000 |
Bid | 0.9500 |
Ask | 3.4000 |
Strike | 22.50 |
Expiry date | 2024-12-20 |
Day's range | 2.1000 - 2.1000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
Key Insights Protagonist Therapeutics to hold its Annual General Meeting on 20th of June Salary of US$655.2k is part of...